Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-15

Clinical Trial Update: Ketogenic Diet in Combination With Standard-of-care Radiation and Temozolomide for Patients With Glioblastoma [Phase 1]

View source ↗

Summary

This Phase 1 trial tested adding a ketogenic diet to standard radiotherapy and temozolomide in glioblastoma and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Temodar (Temozolomide)

Snippet

Sponsor: Jethro Hu | Conditions: GBM, Glioblastoma | Phase 1 | Status: COMPLETED